Bellerophon Therapeutics

BLPH50

Penny Stock

$0.030.00%$0.00

Penny Stock

BLPH50

$0.03

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$0.03
Prev. Close	$0.03
EPS	-0.89
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$452.60K
PE Ratio	-

	LOW	HIGH
Day Range	0.03	0.03
52 Week Range	0.02	0.40

Ratios

Revenue	-





EPS	-0.89

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Bellerophon Therapeutics (BLPH)

Bellerophon Therapeutics Inc (BLPH) is a biopharmaceutical company focused on the development of innovative therapies for cardiopulmonary diseases. The company's goal is to improve the lives of patients suffering from serious respiratory conditions. BLPH is dedicated to developing and commercializing therapies that address significant unmet medical needs in the field of cardiopulmonary diseases.

The company's lead product candidate, INSTRUMENT_SUMMARY, is a proprietary inhaled nitric oxide delivery system. INSTRUMENT_SUMMARY is designed to treat a range of cardiopulmonary diseases, including pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with chronic obstructive pulmonary disease (PH-COPD). Nitric oxide is a potent vasodilator, meaning it relaxes and widens blood vessels, improving blood flow and oxygen delivery to the lungs.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO
Headquarters: Warren
Employees: 18
Exchange: NASDAQ

add Bellerophon Therapeutics to watchlist

Keep an eye on Bellerophon Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Bellerophon Therapeutics 's (BLPH) price per share?

The current price per share for Bellerophon Therapeutics (BLPH) is $0.04. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Bellerophon Therapeutics (BLPH)?

For Bellerophon Therapeutics (BLPH), the 52-week high is $0.41, which is 1.03K% from the current price. The 52-week low is $0.03, the current price is 24.14% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Bellerophon Therapeutics (BLPH) a growth stock?

Bellerophon Therapeutics (BLPH) has shown an average price growth of -6.65% over the past three years. It has received a score of 3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bellerophon Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Bellerophon Therapeutics (BLPH) stock price performance year to date (YTD)?

As of the latest data, Bellerophon Therapeutics (BLPH) has a year-to-date price change of -2.7%. Over the past month, the stock has experienced a price change of 0%. Over the last three months, the change has been 2.86%. Over the past six months, the figure is -36.51%. Looking at a longer horizon, the five-year price change stands at -99.35%.

help

Is Bellerophon Therapeutics (BLPH) a profitable company?

Bellerophon Therapeutics (BLPH) has a net income of -$9.25M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -195.76% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$11.04M. Furthermore, the EBITDA is -$11.04M.

help

What is the market capitalization of Bellerophon Therapeutics (BLPH)?

Bellerophon Therapeutics (BLPH) has a market capitalization of $452.61K. The average daily trading volume is 1.68K, indicating the stock's liquidity and investor engagement.